Bone health agents

Bone health agents has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 2, 2026: “Men faced high fracture risk after prostate cancer drugs”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on bone health agents

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Bone health agent use was associated with a 23% lower fracture risk (adjusted HR = 0.77, 95% CI = 0.70 to 0.83).”
Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancerJournal of the National Cancer Institute2026doi:10.1093/jnci/djag061
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Department of Defense and 4 more
  • 1 of 1 finding with company ties
  • Humans1

What is bone health agents linked with?

1

Studies link bone health agents with bone fracture.

Bone fracture

downin humans1HR 0.77

1 study
  1. Bone health agents are linked with a lower risk of bone fracture in humans (adjusted HR 0.77, 95% CI 0.70–0.83).

    “Bone health agent use was associated with a 23% lower fracture risk (adjusted HR = 0.77, 95% CI = 0.70 to 0.83).”

    Humansmalesn = 10,463

    Men faced high fracture risk after prostate cancer drugs

    Journal of the National Cancer Institute

More on Bone fracture

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Journal of the National Cancer Institute

Men faced high fracture risk after prostate cancer drugs

Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.

Cohort · 10,463 peopleBone fracture